Cornea

CARLSBAD, Calif. — In this Healio Video Perspective from the Women in Ophthalmology Summer Symposium, Penny A. Asbell, MD, FACS, MBA, of the University of Memphis, discusses results from the ARMOR surveillance study.

CARLSBAD, Calif. — In this Healio Video Perspective from the Women in Ophthalmology Summer Symposium, Analisa Arosemena, MD, of CorrectVision Laser Institute discusses Vevye for the treatment of dry eye disease.

In this Healio Video Perspective from the World Ophthalmology Congress, John D. Sheppard, MD, MMSc, FACS, of Virginia Eye Consultants discusses Miebo’s efficacy for dry eye disease in various patient subgroups.

Spencer Trask & Co. announced the launch of Signal12, a clinical-stage dry eye company that plans to advance Pro-ocular for the treatment of dry eye disease, according to a press release.

Patients with dry eye disease experienced improvements in ocular discomfort after treatment with reproxalap, according to a press release from Aldeyra Therapeutics.

Bausch + Lomb has acquired Trukera Medical in an effort to expand its position in dry eye care, according to a press release.

KIAWAH ISLAND, S.C. — A study suggested that electrocardiogram screening should be performed in patients with sarcoidosis-associated uveitis because life-threatening cardiac involvement may be present even without symptoms.

KIAWAH ISLAND, S.C. — In this Healio Video Perspective from Kiawah Eye, Preeya K. Gupta, MD, discusses Vevye’s positive impact on the signs and symptoms of dry eye disease.

Ophthalmologists must work with oncologists to understand and mitigate ocular surface adverse events caused by oncologic therapeutics, according to a presentation at Real World Ophthalmology.

An impending physician shortage has been hanging over ophthalmology for years. The aging population needs more eye care, but as ophthalmologists are aging with that population, there are not enough incoming physicians to take their place.